A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension

Journal of the American Society of Hypertension

Volumn 10, Issue 6, 2016, Pages 510-516.e1

  Corrêa, Nathália Batista ^a   de Faria, Ana Paula ^a   Ritter, Alessandra M V ^a   Sabbatini, Andrea Rodrigues ^a   Almeida, Aurélio ^a   Brunelli, Veridiana ^a   Calhoun, David A ^b   Moreno, Heitor ^a   Modolo, Rodrigo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b University of Alabama at Birmingham   (United States)

Author keywords

Pharmacological adherence; refractory hypertension; triamterene; urine fluorescence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FLUORESCENCE; FLUOROMETRY; HUMAN; HYPERTENSION; MALE; MEDICATION COMPLIANCE; MORISKY MEDICATION ADHERENCE SCALE; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE; RESISTANT HYPERTENSION; URINE SAMPLING; AGED; CLINICAL TRIAL; CORONARY ARTERY SPASM; FEASIBILITY STUDY; MIDDLE AGED; PSYCHOLOGY; SENSITIVITY AND SPECIFICITY; URINE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CORONARY VASOSPASM; DIURETICS; FEASIBILITY STUDIES; FEMALE; FLUOROMETRY; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; TRIAMTERENE;

EID: 84965082049     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2016.03.194     Document Type: Article

References (32)

1. 1 Calhoun, D.A., Jones, D., Textor, S., Goff, D.C., Murphy, T.P., Toto, R.D., et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51:6 (2008), 1403–1419.
2. 2 de Souza, W.A., Sabha, M., de Faveri Favero, F., Bergsten-Mendes, G., Yugar-Toledo, J.C., Moreno, H., Intensive monitoring of adherence to treatment helps to identify “true” resistant hypertension. J Clin Hypertens (Greenwich) 11:4 (2009), 183–191.
3. 3 Yiannakopoulou, E., Papadopulos, J.S., Cokkinos, D.V., Mountokalakis, T.D., Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 12:3 (2005), 243–249.
4. 4 Brown, M.J., Resistant hypertension: resistance to treatment or resistance to taking treatment?. Heart 100:11 (2014), 821–822.
5. 5 Achelrod, D., Wenzel, U., Frey, S., Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens 28:3 (2015), 355–361.
6. 6 Tomaszewski, M., White, C., Patel, P., Masca, N., Damani, R., Hepworth, J., et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart 100:11 (2014), 855–861.
7. 7 Jung, O., Gechter, J.L., Wunder, C., Paulke, A., Bartel, C., Geiger, H., et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 31:4 (2013), 766–774.
8. 8 Patel, P., Gupta, P.K., White, C.M., Stanley, A.G., Williams, B., Tomaszewski, M., Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation. J Hum Hypertens, 2015.
9. 9 Carda-Broch, S., Esteve-Romero, J.S., Garcia-Alvarez-Coque, M.C., Chromatographic determination of diuretics in urine samples using hybrid micellar mobile phases with fluorimetric detection. Analytica Chimica Acta 375:1-2 (1998), 143–154.
10. 10 Luscher, T., Tuma, J., Scheu, H., Haase, W., Tenschert, W., Ammann, D., et al. [Compliance in hypertensive patients and patients with cardiac insufficiency]. Schweiz Med Wochenschr 111:52 (1981), 2047–2050.
11. 11 Foerster, E.C., Achermann, R., Groth, H., Edmonds, D., Siegenthaler, W., Vetter, W., [Does self-measurement of blood pressure improve compliance in hypertensive patients?]. Schweiz Med Wochenschr 115:5 (1985), 163–165.
12. 12 Morisky, D.E., Ang, A., Krousel-Wood, M., Ward, H.J., Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10:5 (2008), 348–354.
13. 13 de Oliveira-Filho, A.D., Morisky, D.E., Neves, S.J., Costa, F.A., de Lyra, D.P. Jr., The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults. Res Social Adm Pharm 10:3 (2014), 554–561.
14. 14 Parati, G., Stergiou, G.S., Asmar, R., Bilo, G., de Leeuw, P., Imai, Y., et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 24:12 (2010), 779–785.
15. 15 Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:7 (2013), 1281–1357.
16. 16 Oliveira-Filho, A.D., Barreto-Filho, J.A., Neves, S.J., Lyra, D.P. Junior, Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control. Arq Bras Cardiol 99:1 (2012), 649–658.
17. 17 BAYER, A.G., Use of triamterene as chemical marker—for detection in urine as test of patient compliance. 1988 Germany.
18. 18 Sabate, E., Adherence to long-term therapies: evidence for action. 2003, World Health Organization, Geneva.
19. 19 Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:6 (2003), 1206–1252.
20. 20 Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 29:3 (2011), 610–618.
21. 21 Mazzaglia, G., Ambrosioni, E., Alacqua, M., Filippi, A., Sessa, E., Immordino, V., et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 120:16 (2009), 1598–1605.
22. 22 Perreault, S., Yu, A.Y., Cote, R., Dragomir, A., White-Guay, B., Dumas, S., Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. Neurology 79:20 (2012), 2037–2043.
23. 23 Judd, E., Calhoun, D.A., Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens 28:8 (2014), 463–468.
24. 24 Pierdomenico, S.D., Lapenna, D., Bucci, A., Di Tommaso, R., Di Mascio, R., Manente, B.M., et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 18:11 (2005), 1422–1428.
25. 25 Farmer, K.C., Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21:6 (1999), 1074–1090 discussion 1073.
26. 26 Osterberg, L., Blaschke, T., Adherence to medication. N Engl J Med 353:5 (2005), 487–497.
27. 27 Burnier, M., Wuerzner, G., Struijker-Boudier, H., Urquhart, J., Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension 62:2 (2013), 218–225.
28. 28 Pandey, A., Raza, F., Velasco, A., Brinker, S., Ayers, C., Das, S.R., et al. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens 9:6 (2015), 420–426 e2.
29. 29 Wenzel, U., Stange, D., Dusing, R., A simple test to appreciate compliance with antihypertensive drug therapy. J Hypertens, 30(3), 2012, 624 author reply 625.
30. 30 Dominguez-Vidal, A., Ortega-Barrales, P., Molina-Diaz, A., Determination of triamterene by transitory retention in a continuous flow solid phase system with fluorimetric transduction. J Pharm Biomed Anal 28:3-4 (2002), 721–728.
31. 31 Brinker, S., Pandey, A., Ayers, C., Price, A., Raheja, P., Arbique, D., et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol 63:8 (2014), 834–835.
32. 32 Bhatt, D.L., Kandzari, D.E., O'Neill, W.W., D'Agostino, R., Flack, J.M., Katzen, B.T., et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370:15 (2014), 1393–1401.